Nordea Investment Management
LEGN icon

Nordea Investment Management’s Legend Biotech LEGN Stock Holding History

Nordea Investment Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-71,134
Closed -$1.28M – 946
2026
Q1 		$1.28M Sell
71,134
-2,427
-3% -$46.3K ﹤0.01% 805
2025
Q4 		$1.6M Buy
73,561
+10,370
+16% +$297K ﹤0.01% 779
2025
Q3 		$2.09M Buy
63,191
+2,478
+4% +$91.5K ﹤0.01% 732
2025
Q2 		$2.2M Sell
60,713
-242,617
-80% -$7.86M ﹤0.01% 716
2025
Q1 		$10.1M Buy
303,330
+37,098
+14% +$1.33M 0.01% 398
2024
Q4 		$8.68M Buy
266,232
+33,024
+14% +$1.37M 0.01% 436
2024
Q3 		$11.3M Sell
233,208
-5,392
-2% -$287K 0.01% 389
2024
Q2 		$10.6M Buy
238,600
+223,613
+1,492% +$10.3M 0.01% 396
2024
Q1 		$843K Buy
+14,987
New +$904K ﹤0.01% 844

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nordea Investment Management's LEGN Position: Q2 2026 in Review

Nordea Investment Management sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 71,134 shares — an estimated $1.28M sold.

Nordea Investment Management first reported a position in LEGN in Q1 2024 and held it in 9 quarters. The position peaked at $11.3M in Q3 2024. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Nordea Investment Management reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Nordea Investment Management sold 71,134 Legend Biotech shares in Q2 2026, an estimated $1.28M.
  • Nordea Investment Management first reported a position in Legend Biotech in Q1 2024 and held it in 9 quarters.
  • Nordea Investment Management's Legend Biotech position peaked at $11.3M in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.